520 related articles for article (PubMed ID: 9267734)
1. Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.
Godt O; Proksch E; Streit V; Christophers E
Dermatology; 1997; 195(1):35-9. PubMed ID: 9267734
[TBL] [Abstract][Full Text] [Related]
2. Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A.
Mackey S; Pride HB; Tyler WB
Arch Dermatol; 1996 Dec; 132(12):1429-30. PubMed ID: 8961869
[No Abstract] [Full Text] [Related]
3. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
4. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.
Vella Briffa D; Eady RA; James MP; Gatti S; Bleehen SS
Br J Dermatol; 1983 Jul; 109(1):67-75. PubMed ID: 6860573
[TBL] [Abstract][Full Text] [Related]
5. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
6. [Consensus document on bath-PUVA therapy. The Spanish Photobiology Group of the Spanish Academy of Dermatology and Venereology].
Rodríguez-Granados MT; Carrascosa JM; Gárate T; Gómez-Díez S; Guimaraens-Juantorena D
Actas Dermosifiliogr; 2007 Apr; 98(3):164-70. PubMed ID: 17504700
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic palmoplantar eczema with local bath-PUVA therapy.
Schempp CM; Müller H; Czech W; Schöpf E; Simon JC
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):733-7. PubMed ID: 9146535
[TBL] [Abstract][Full Text] [Related]
8. Treatment of psoriasis with polyethylene sheet bath PUVA.
Streit V; Wiedow O; Christophers E
J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of bath psoralen plus ultraviolet A (PUVA) vs. system PUVA in psoriasis: a prospective, open, randomized, multicentre study.
Berneburg M; Herzinger T; Rampf J; Hoetzenecker W; Guenova E; Meisner C; Maetzke J; Schaefer T; Eberlein B; Scharffetter-Kochanek K; Rocken M
Br J Dermatol; 2013 Sep; 169(3):704-8. PubMed ID: 23772997
[TBL] [Abstract][Full Text] [Related]
10. Bath-PUVA therapy improves impaired resting regulatory T cells and increases activated regulatory T cells in psoriasis.
Kubo R; Muramatsu S; Sagawa Y; Saito C; Kasuya S; Nishioka A; Nishida E; Yamazaki S; Morita A
J Dermatol Sci; 2017 Apr; 86(1):46-53. PubMed ID: 28139335
[TBL] [Abstract][Full Text] [Related]
11. [PUVA therapy of mastocytosis patients].
Kasimov N
Vestn Dermatol Venerol; 1986; (1):28-31. PubMed ID: 3962480
[No Abstract] [Full Text] [Related]
12. Decreased urinary histamine metabolite after successful PUVA treatment of urticaria pigmentosa.
Granerus G; Roupe G; Swanbeck G
J Invest Dermatol; 1981 Jan; 76(1):1-3. PubMed ID: 7462662
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
[TBL] [Abstract][Full Text] [Related]
14. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
15. Paired comparison of bathwater versus oral delivery of 8-methoxypsoralen in psoralen plus ultraviolet: A therapy for chronic palmoplantar psoriasis.
Hofer A; Fink-Puches R; Kerl H; Quehenberger F; Wolf P
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):1-5. PubMed ID: 16436174
[TBL] [Abstract][Full Text] [Related]
16. [Urticaria pigmentosa and systemic mastocytosis].
Roupe G
Lakartidningen; 1989 Apr; 86(15):1370-2. PubMed ID: 2716450
[No Abstract] [Full Text] [Related]
17. [Benign systemic mastocytosis: report of 2 cases].
Velloso ED; Beitler B; Chamone DA
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):94-8. PubMed ID: 1843375
[TBL] [Abstract][Full Text] [Related]
18. Photochemotherapy of dominant, diffuse, cutaneous mastocytosis.
Smith ML; Orton PW; Chu H; Weston WL
Pediatr Dermatol; 1990 Dec; 7(4):251-5. PubMed ID: 2080117
[TBL] [Abstract][Full Text] [Related]
19. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
